• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾单位中的权衡:一种解释磷酸盐在继发性甲状旁腺功能亢进发病机制中首要地位的理论。

Tradeoff-in-the-Nephron: A Theory to Explain the Primacy of Phosphate in the Pathogenesis of Secondary Hyperparathyroidism.

作者信息

Phelps Kenneth R

机构信息

Research Service, Stratton Veterans' Affairs Medical Center, Albany, NY 12208, USA.

Department of Medicine, Division of Nephrology, Albany Medical College, Albany, NY 12208, USA.

出版信息

Nutrients. 2017 Apr 26;9(5):427. doi: 10.3390/nu9050427.

DOI:10.3390/nu9050427
PMID:28445401
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5452157/
Abstract

Chronic kidney disease (CKD) causes secondary hyperparathyroidism (SHPT). The cardinal features of SHPT are persistence of normocalcemia as CKD progresses and dependence of the parathyroid hormone concentration ([PTH]) on phosphate influx (I). The tradeoff-in-the-nephron hypothesis integrates these features. It states that as the glomerular filtration rate (GFR) falls, the phosphate concentration ([P]) rises in the cortical distal nephron, the calcium concentration ([Ca]) in that segment falls, and [PTH] rises to maintain normal calcium reabsorption per volume of filtrate (TR/GFR). In a clinical study, we set GFR equal to creatinine clearance (C) and I equal to the urinary excretion rate of phosphorus (E). We employed E/C as a surrogate for [P]. We showed that TR/C was high in patients with primary hyperparathyroidism (PHPT) and normal in those with SHPT despite comparably increased [PTH] in each group. In subjects with SHPT, we examined regressions of [PTH] on E/C before and after treatment with sevelamer carbonate or a placebo. All regressions were significant, and ∆[PTH] correlated with ∆E/C in each treatment cohort. We concluded that [P] determines [PTH] in CKD. This inference explains the cardinal features of SHPT, much of the evidence on which other pathogenic theories are based, and many ancillary observations.

摘要

慢性肾脏病(CKD)会引发继发性甲状旁腺功能亢进(SHPT)。SHPT的主要特征是随着CKD进展血钙正常持续存在,且甲状旁腺激素浓度([PTH])依赖于磷流入量(I)。肾单位权衡假说整合了这些特征。该假说指出,随着肾小球滤过率(GFR)下降,皮质远端肾单位中的磷浓度([P])升高,该节段中的钙浓度([Ca])下降,[PTH]升高以维持每单位滤液(TR/GFR)的正常钙重吸收。在一项临床研究中,我们将GFR等同于肌酐清除率(C),将I等同于磷的尿排泄率(E)。我们采用E/C作为[P]的替代指标。我们发现,尽管两组患者的[PTH]均有相当程度的升高,但原发性甲状旁腺功能亢进(PHPT)患者的TR/C较高,而SHPT患者的TR/C正常。在SHPT患者中,我们检查了使用碳酸司维拉姆或安慰剂治疗前后[PTH]对E/C的回归情况。所有回归均具有显著性,且在每个治疗队列中,∆[PTH]与∆E/C相关。我们得出结论,在CKD中[P]决定[PTH]。这一推断解释了SHPT的主要特征、许多其他致病理论所基于的证据以及许多辅助观察结果。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/345a/5452157/07e9c6e8e959/nutrients-09-00427-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/345a/5452157/92567fa0e4d1/nutrients-09-00427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/345a/5452157/07e9c6e8e959/nutrients-09-00427-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/345a/5452157/92567fa0e4d1/nutrients-09-00427-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/345a/5452157/07e9c6e8e959/nutrients-09-00427-g002.jpg

相似文献

1
Tradeoff-in-the-Nephron: A Theory to Explain the Primacy of Phosphate in the Pathogenesis of Secondary Hyperparathyroidism.肾单位中的权衡:一种解释磷酸盐在继发性甲状旁腺功能亢进发病机制中首要地位的理论。
Nutrients. 2017 Apr 26;9(5):427. doi: 10.3390/nu9050427.
2
Use of sevelamer to examine the role of intraluminal phosphate in the pathogenesis of secondary hyperparathyroidism.使用司维拉姆研究管腔内磷酸盐在继发性甲状旁腺功能亢进发病机制中的作用。
Clin Nephrol. 2014 Sep;82(3):191-201. doi: 10.5414/cn108227.
3
Chemical evidence for the tradeoff-in-the-nephron hypothesis to explain secondary hyperparathyroidism.化学证据支持肾单位内权衡假说解释继发性甲状旁腺功能亢进症。
PLoS One. 2022 Aug 1;17(8):e0272380. doi: 10.1371/journal.pone.0272380. eCollection 2022.
4
An examination of multiple explanations for secondary hyperparathyroidism
.对继发性甲状旁腺功能亢进多种解释的研究。
Clin Nephrol. 2020 Aug;94(2):70-77. doi: 10.5414/CN110043.
5
Phosphate homeostasis, parathyroid hormone, and fibroblast growth factor 23 in stages 3 and 4 chronic kidney disease.3期和4期慢性肾脏病中的磷稳态、甲状旁腺激素和成纤维细胞生长因子23
Clin Nephrol. 2016 May;85(5):251-61. doi: 10.5414/CN108686.
6
Parathyroid Hormone, Fibroblast Growth Factor 23, and Parameters of Phosphate Reabsorption.甲状旁腺激素、成纤维细胞生长因子 23 和磷酸盐重吸收参数。
Am J Nephrol. 2018;47(5):343-351. doi: 10.1159/000489270. Epub 2018 May 18.
7
Tubular calcium reabsorption and other aspects of calcium homeostasis in primary and secondary hyperparathyroidism.原发性和继发性甲状旁腺功能亢进症中肾小管钙重吸收及钙稳态的其他方面
Clin Nephrol. 2014 Aug;82(2):83-91. doi: 10.5414/CN108223.
8
Cinacalcet HCl: a novel treatment for secondary hyperparathyroidism caused by chronic kidney disease.盐酸西那卡塞:一种治疗慢性肾脏病所致继发性甲状旁腺功能亢进的新疗法。
J Ren Nutr. 2006 Jul;16(3):253-8. doi: 10.1053/j.jrn.2006.04.010.
9
1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.1α(OH)D3 一α-羟基胆钙化醇——一种活性维生素 D 类似物。关于慢性透析的尿毒症患者继发性甲状旁腺功能亢进症预防和治疗的临床研究。
Dan Med Bull. 2008 Nov;55(4):186-210.
10
Reduced parathyroid hormone-stimulated 1,25-dihydroxyvitamin d production in vitamin d sufficient postmenoposual women with low bone mass and idiopathic secondary hyperparathyroidism.维生素 D 充足的绝经后低骨量和特发性继发性甲状旁腺功能亢进症妇女中,甲状旁腺激素刺激 1,25-二羟维生素 D 生成减少。
Endocr Pract. 2013 Jan-Feb;19(1):91-9. doi: 10.4158/EP12151.OR.

引用本文的文献

1
Association of serum calcium levels with diabetic kidney disease in normocalcemic type 2 diabetes patients: a cross-sectional study.血清钙水平与正常血钙 2 型糖尿病患者糖尿病肾病的相关性:一项横断面研究。
Sci Rep. 2024 Sep 14;14(1):21513. doi: 10.1038/s41598-024-72747-8.
2
Chemical evidence for the tradeoff-in-the-nephron hypothesis to explain secondary hyperparathyroidism.化学证据支持肾单位内权衡假说解释继发性甲状旁腺功能亢进症。
PLoS One. 2022 Aug 1;17(8):e0272380. doi: 10.1371/journal.pone.0272380. eCollection 2022.
3
Mediation of the relationship between proteinuria and serum phosphate: Insight from the KNOW-CKD study.

本文引用的文献

1
Evidence that TmP/GFR can be estimated with the Walton-Bijvoet nomogram in chronic kidney disease
.有证据表明,在慢性肾脏病中,可使用沃尔顿-比约弗特列线图来估算肾小管磷重吸收率/肾小球滤过率。
Clin Nephrol. 2017 Jul;88(1):19-26. doi: 10.5414/CN109069.
2
Vitamin D Deficiency - Is There Really a Pandemic?维生素D缺乏——真的是一场大流行吗?
N Engl J Med. 2016 Nov 10;375(19):1817-1820. doi: 10.1056/NEJMp1608005.
3
Use of Extended-Release Calcifediol to Treat Secondary Hyperparathyroidism in Stages 3 and 4 Chronic Kidney Disease.使用缓释骨化二醇治疗3期和4期慢性肾脏病继发性甲状旁腺功能亢进症。
蛋白尿与血清磷酸盐关系的中介作用:来自 KNOW-CKD 研究的见解。
PLoS One. 2020 Jun 22;15(6):e0235077. doi: 10.1371/journal.pone.0235077. eCollection 2020.
Am J Nephrol. 2016;44(4):316-325. doi: 10.1159/000450766. Epub 2016 Sep 28.
4
Fgf23 and parathyroid hormone signaling interact in kidney and bone.成纤维细胞生长因子23(Fgf23)与甲状旁腺激素信号在肾脏和骨骼中相互作用。
Mol Cell Endocrinol. 2016 Nov 15;436:224-39. doi: 10.1016/j.mce.2016.07.035. Epub 2016 Aug 4.
5
Hip Fracture in Patients With Non-Dialysis-Requiring Chronic Kidney Disease.非透析依赖性慢性肾脏病患者的髋部骨折
J Bone Miner Res. 2016 Oct;31(10):1803-1809. doi: 10.1002/jbmr.2862. Epub 2016 Jul 11.
6
Phosphate homeostasis, parathyroid hormone, and fibroblast growth factor 23 in stages 3 and 4 chronic kidney disease.3期和4期慢性肾脏病中的磷稳态、甲状旁腺激素和成纤维细胞生长因子23
Clin Nephrol. 2016 May;85(5):251-61. doi: 10.5414/CN108686.
7
Parameters of phosphorus homeostasis at normal and reduced GFR: empiric observations.正常及降低的肾小球滤过率时磷稳态的参数:经验性观察
Clin Nephrol. 2015 Apr;83(4):208-17. doi: 10.5414/CN108380.
8
Parameters of phosphorus homeostasis at normal and reduced GFR: theoretical considerations.正常及降低的肾小球滤过率时磷稳态的参数:理论探讨
Clin Nephrol. 2015 Mar;83(3):167-76. doi: 10.5414/cn108367.
9
Modified-release calcifediol effectively controls secondary hyperparathyroidism associated with vitamin D insufficiency in chronic kidney disease.缓释骨化二醇可有效控制慢性肾脏病中与维生素D缺乏相关的继发性甲状旁腺功能亢进。
Am J Nephrol. 2014;40(6):535-45. doi: 10.1159/000369939. Epub 2015 Jan 7.
10
A 12-week, double-blind, placebo-controlled trial of ferric citrate for the treatment of iron deficiency anemia and reduction of serum phosphate in patients with CKD Stages 3-5.一项为期 12 周、双盲、安慰剂对照的柠檬酸铁治疗慢性肾脏病 3-5 期患者铁缺乏性贫血和降低血磷的试验。
Am J Kidney Dis. 2015 May;65(5):728-36. doi: 10.1053/j.ajkd.2014.10.014. Epub 2014 Nov 4.